Donor BMI and Post–living Donor Liver Transplantation Outcomes: A Preliminary Report

Background. Living liver donor obesity has been considered a relative contraindication to living donation given the association with hepatic steatosis and potential for poor donor and recipient outcomes. We investigated the association between donor body mass index (BMI) and donor and recipient posttransplant outcomes. Methods. We studied 66 living donors and their recipients who underwent living donor liver transplant at our center between 2013 and 2020. BMI was divided into 3 categories (<25, 25–29.9, and ≥30 kg/m2). Magnetic resonance imaging–derived proton density fat fraction was used to quantify steatosis. Donor outcomes included length of stay (LOS), emergency department visits within 90 d, hospital readmissions within 90 d, and complication severity. Recipient outcomes included LOS and in-hospital mortality. The Student t test was used to compare normally distributed variables, and Kruskal-Wallis tests were used for nonparametric data. Results. There was no difference in donor or recipient characteristics based on donor BMI. There was no significant difference in mean magnetic resonance imaging fat percentage among the 3 groups. Additionally, there was no difference in donor LOS (P = 0.058), emergency department visits (P = 0.64), and hospital readmissions (P = 0.66) across BMI category. Donor complications occurred in 30 patients. There was no difference in postdonation complications across BMI category (P = 0.19); however, there was a difference in wound complications, with the highest rate being seen in the highest BMI group (0% versus 16% versus 37%; P = 0.041). Finally, there was no difference in recipient LOS (P = 0.83) and recipient in-hospital mortality (P = 0.29) across BMI category. Conclusions. Selecting donors with BMI ≥30 kg/m2 can result in successful living donor liver transplantation; however, they are at risk for perioperative wound complications. Donor counseling and perioperative strategies to mitigate wound-related issues should be used when considering obese living donors.

[1]  B. Samstein,et al.  Practice patterns of the medical evaluation of living liver donors in the United States , 2022, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  Sharon R. Weeks,et al.  Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  A. Israni,et al.  OPTN/SRTR 2019 Annual Data Report: Liver , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  K. Suh,et al.  Influence of Body Mass Index ≥30 on Pure Laparoscopic Donor Right Hepatectomy , 2020, Annals of transplantation.

[5]  A. Mangia,et al.  Noninvasive Diagnosis of NAFLD and NASH , 2020, Cells.

[6]  Raju Sharma,et al.  Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index. , 2020, Journal of clinical and experimental hepatology.

[7]  Rohit Loomba,et al.  Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. , 2019, Gastroenterology.

[8]  M. Domínguez Bastante,et al.  Influence of Donor Obesity on Long-Term Liver Transplantation Outcomes. , 2019, Transplantation proceedings.

[9]  Rohit Loomba,et al.  Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials , 2018, Hepatology.

[10]  S. Serai,et al.  Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors , 2018, Abdominal Radiology.

[11]  N. Selzner,et al.  Donor BMI >30 Is Not a Contraindication for Live Liver Donation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  E. Haglind,et al.  Retrospective review of risk factors for surgical wound dehiscence and incisional hernia , 2017, BMC Surgery.

[13]  J. Zagzebski,et al.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy. , 2017, AJR. American journal of roentgenology.

[14]  U. Neumann,et al.  Liver Transplantation and Donor Body Mass Index >30: Use or Refuse? , 2016, Annals of transplantation.

[15]  R. Idilman,et al.  Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. , 2013, Radiology.

[16]  J. Yang,et al.  Body mass index evaluating donor hepatic steatosis in living donor liver transplantation. , 2009, Transplantation proceedings.

[17]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[18]  C. Lo,et al.  Liver transplantation for hepatocellular carcinoma in Asia. , 2007, The oncologist.

[19]  J. Emond,et al.  Select Utilization of Obese Donors in Living Donor Liver Transplantation: Implications for the Donor Pool , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  M. Bondi,et al.  Hepatic steatosis in obese patients: clinical aspects and prognostic significance , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[21]  M. Abecassis,et al.  Body mass index as a predictor of hepatic steatosis in living liver donors , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[22]  Y Koido,et al.  Successful liver transplantation from a living donor to her son. , 1990, The New England journal of medicine.